Mixed Anxiety Disorders Clinical Trial
Official title:
Metacognitive Therapy Versus Cognitive Behavioral Therapy for Mixed Anxiety Disorders: A Randomized Controlled Trial.
Comorbidity is normal in clinical practice. Metacognitive Therapy (MCT) is a transdiagnostic
model and could therefore be well suited when it comes to treating patients with high rates
of comorbidity. So far, no studies have examined MCT in comparison with the best documented
and evidence based treatment, cognitive behavioral treatment(CBT), in a randomized
controlled trial consisting of mixed anxiety disorder sample with high degree of
comorbidity.
The main aim of this study is to 1) Evaluate the effectiveness of metacognitive therapy in a
sample of mixed anxiety disorders as compared to a group receiving existing evidence-based
single diagnosis CBT- treatment protocols 2) Investigate patterns and mechanisms of change
in the two treatments.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment